[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366799-105":59,"doc-detail-366799-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","risk-of-gynaecologic-cancers-in-women-with-metabolic-syndrome-a-systematic-review-meta-analysis","Risk of gynaecologic cancers in women with metabolic syndrome - A systematic review & meta-analysis","","Metabolic syndrome may be linked to the development of gynaecological cancers. This systematic review evaluated the risk of cervical, uterine/endometrial, ovarian, and other gynaecologic cancers among women with metabolic syndrome. English-language studies were searched in PubMed, Google Scholar, and Scopus through September 12-14, 2023, with duplicate removal, screening by two reviewers, critical appraisal using JBI and AXIS checklists, and structured data extraction. Results indicate increased risks across study designs, with GRADE reporting low-quality evidence for cervical, uterine/endometrial, and ovarian cancers.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/risk-of-gynaecologic-cancers-in-women-with-metabolic-syndrome-a-systematic-review-meta-analysis/366799/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/risk-of-gynaecologic-cancers-in-women-with-metabolic-syndrome-a-systematic-review-meta-analysis/366799.png","ImageObject",300,407,{"name":92,"@type":93},"awa","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What question does the systematic review address?","Question",{"text":113,"@type":114},"It assesses whether metabolic syndrome is associated with the risk of gynaecologic cancers in women.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which study selection and appraisal methods were used?",{"text":118,"@type":114},"English studies were identified from PubMed, Google Scholar, and Scopus through September 12-14, 2023, screened by two independent reviewers, and appraised using JBI checklists and the AXIS checklist.",{"name":120,"@type":111,"acceptedAnswer":121},"What do the results suggest about cancer risk?",{"text":122,"@type":114},"Across case-control, cross-sectional, and cohort studies, metabolic syndrome was associated with increased risks for uterine/endometrial cancer and indications of association for ovarian and cervical cancer outcomes.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},366799,1790276777,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},3985747858093,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Indian J Med Res 162, August 2025, pp 197-210 DOI: 10.25259/IJMR_588_2025  \nSystematic Review  \nRisk of gynaecologic cancers in women with metabolic syndrome: A systematic review & meta-analysis  \nIndra Kundu 1, Denny John2, Iqra Ansari1, Keechilat Pavithran3 & Susan Idicula-Thomas1  \n1Department of Biomedical Informatics Center, ICMR-National Institute of Research in Reproductive and Child Health, Mumbai, Maharashtra, 2Department of Allied Health Sciences, Faculty of Life and Allied Health Sciences, MS Ramaiah University of Applied Sciences, Bengaluru, Karnataka, & 3Department of Medical Oncology, Amrita Institute of Medical Sciences and Research Centre, Amrita Vishwa Vidhyapeetham, Kochi, Kerela, India  \nReceived March 7, 2025; Accepted June 2, 2025; Published October 10, 2025  \nBackground & objectives: Metabolic syndrome may be associated with the risk of gynaecological cancers.  \nThis systematic review aims to evaluate the risk of gynaecological cancers among women with metabolic  \nsyndrome.  \nMethods: Studies published in English using a search strategy across PubMed, Google Scholar, and Scopus were identified from the earliest available indexing of the respective databases up to September 12-14, 2023. After removing duplicates and conducting a detailed screening by two independent reviewers, 25 studies were identified. Critical appraisal was conducted using JBI checklists for casecontrol and cohort studies and AXIS checklist for cross-sectional studies. Data extraction was conducted for information pertaining to study design, participant demographics, definition of metabolic syndrome,  \nreported summary measures and type of gynaecological cancer.  \nResults: Random effects models were employed separately for each study design, reported summary measures and the type of gynaecological cancers. In case-control, cross-sectional, and cohort studies, presence of metabolic syndrome was associated with uterine/endometrial cancer [odds ratio (OR) 1.99, P\u003C0.01, OR 2.64, P\u003C0.01, hazard ratio (HR) 1.45, P=0.04], respectively. Case-control and cohort studies in ovarian cancer suggested association (OR 3.44, P\u003C0.01, OR 1.02, P=0.79, and HR 1.02, P=0.80).  \nCohort studies in cervical cancer patients, yielded HR 1.26, P=0.96 and adjusted HR 1.27, P=0.83. The  \ncritical appraisal of the included studies was high. GRADE reported low-quality evidence for cervical,  \nuterine/endometrial, and ovarian cancer.  \nInterpretation & conclusions: Women with metabolic syndrome are associated with increased risk of gynaecological cancers regardless of study design, type of gynaecological cancer and definitions of  \nmetabolic syndrome.  \nKey words Cervical cancer-endometrial cancer-metabolic syndrome-ovarian cancer-risk-vaginal cancer  \nMetabolic syndrome is a multifactorial disorder comprising of obesity, hyperglycaemia, hypertension,  \nhigh triglycerides (TG) and low high-density lipoprotein cholesterol (HDLc) 1. Various organisations have defined  \n© 2025 Indian Journal of Medical Research, published by Scientific Scholar for Director-General, Indian Council of Medical Research  \nThis open access publication is protected under CC-BY-NC-SA 4.0  \n198 INDIAN J MED RES, AUGUST 2025  \nthe syndrome through different thresholds and criteria for these components2. Despite the dissimilarities, the definitions converge on the simultaneous occurrence of three out of five components [adult treatment panel III (ATP III), harmonised definition (HD) with either obesity (International Diabetes Federation, IDF) or insulin resistance (World Health Organization, WHO)] as a mandatory component for diagnosis of metabolic syndrome2. The co-occurrence of these metabolic abnormalities increases the risk of cardiovascular diseases, type 2 diabetes and cancers.  \nSeveral clinical and epidemiological studies have investigated the risk of gynaecologic cancers and metabolic syndrome worldwide. These studies mainly report inconclusive findings which may be attributed to varying ","cbCaitFd75QTCCSL","https://ap.wps.com/l/cbCaitFd75QTCCSL","pdf",999701,14,"English","# Background & objectives\n# Methods\n# Results\n# Interpretation & conclusions\n# Key words\n## Definitions of metabolic syndrome\n## Evidence from prior studies","[{\"question\":\"What question does the systematic review address?\",\"answer\":\"It assesses whether metabolic syndrome is associated with the risk of gynaecologic cancers in women.\"},{\"question\":\"Which study selection and appraisal methods were used?\",\"answer\":\"English studies were identified from PubMed, Google Scholar, and Scopus through September 12-14, 2023, screened by two independent reviewers, and appraised using JBI checklists and the AXIS checklist.\"},{\"question\":\"What do the results suggest about cancer risk?\",\"answer\":\"Across case-control, cross-sectional, and cohort studies, metabolic syndrome was associated with increased risks for uterine/endometrial cancer and indications of association for ovarian and cervical cancer outcomes.\"}]","Risk of gynaecologic cancers in women with metabolic syndrome - A systematic review & meta-analysis | PDF",1790167535,35,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ca84dbc5787d460d1f5ca3354fb644f.webp",983,1272,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c413c34db5adf7e588a9690ca299f78.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ebc020cceeb22b19b7253ccd7dc2bad.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f251e50c857d918de0e52ba0857862f4.webp",980,1268]